Puberty

Normal Puberty Changes in Males and Females

• Age of Onset: Typically begins between ages 9-14 for girls and 10-15 for boys.

• Physical Changes in Males:

  • Growth of testes and scrotum.

  • Penile enlargement.

  • Increased body and facial hair.

  • Deepening of the voice.

  • Growth spurts (in height).

  • Increased muscle mass.

• Physical Changes in Females:

  • Development of breasts.

  • Menstruation begins (usually around age 12).

  • Growth of body hair (armpits and pubic area).

  • Growth spurts (in height).

  • Changes in body composition (more fat distributed around hips and thighs).

• Emotional and Psychological Changes:

  • Increased mood swings due to hormonal changes.

  • Development of sexual interest and feelings.

  • Growing sense of identity and self-awareness.

Precocious Puberty: Precocious puberty is defined as the onset of secondary sexual characteristics before age 9 in boys and before age 8 in girls. It can be caused by hormonal imbalances, conditions affecting the brain (such as tumors), exposure to external sources of hormones, or certain genetic factors. Symptoms may include early breast development, pubic hair growth, and early onset of menstruation in girls, as well as enlarged testes and penis growth, increased body hair, and early voice changes in boys. Diagnosis typically involves physical exams, medical history, and hormone level testing. Treatment may include medication to delay further development and manage symptoms.

Normal Sexual Maturation by Tanner Stages

Tanner Stages for Males:

• Stage 1 (Prepubertal): No pubic hair; penis and testicles are of child size.

• Stage 2: Testicular enlargement; pubic hair begins to appear; penis starts to enlarge.

• Stage 3: Further enlargement of the penis and testes; pubic hair thickens, becomes coarser.

• Stage 4: Penis grows in length and circumference; development of glans; adult-type pubic hair, but not yet in an adult distribution.

• Stage 5 (Adult): Full development of genitalia and pubic hair in adult distribution.

Tanner Stages for Females:

• Stage 1 (Prepubertal): No breast tissue; no pubic hair.

• Stage 2: Breast budding occurs; some pubic hair appears (usually sparse).

• Stage 3: Further breast development; pubic hair becomes coarser and darker.

• Stage 4: Areola and nipple project; adult-type pubic hair but not extending to the thighs.

• Stage 5 (Adult): Fully developed breasts; adult-type pubic hair in an adult distribution, including inner thighs.

Workup for Precocious Puberty:

1. Medical History:

   • Detailed history of growth and development.

   • Family history of early puberty or endocrine disorders.

   • Assessment of any symptoms (e.g., behavioral changes, secondary sexual characteristics).

2. Physical Examination:

   • Assessment of secondary sexual characteristics.

   • Evaluation of growth patterns (height, weight).

3. Laboratory Tests:

   • Hormone level tests (e.g., LH, FSH, estradiol, testosterone) to evaluate for abnormal hormone levels.

   • Thyroid function tests (TSH, T4) to rule out thyroid disorders.

   • Testosterone levels (in girls) to assess for androgen excess.

4. Imaging Studies:

   • X-rays of the hand and wrist to assess bone age, which can indicate early skeletal maturation.

   • MRI of the brain if there is suspicion of any central nervous system abnormalities (e.g., tumors).

   • Ultrasound of the ovaries or testes if indicated to rule out tumors or cysts.

5. Consultation:

   • Referral to a pediatric endocrinologist for further evaluation and management, if necessary.

Common Forms of Hypogonadism:

1. Primary Hypogonadism:

   • Occurs when the testes or ovaries are not functioning properly due to issues in the gonads themselves.

   • Causes include Klinefelter syndrome (male), Turner syndrome (female), or damage from infection, trauma, or radiation.

2. Secondary Hypogonadism:

   • Results from problems in the pituitary gland or hypothalamus leading to inadequate stimulation of the gonads.

   • Causes include Kallmann syndrome, pituitary tumors, or conditions affecting hormone signaling, such as obesity or significant illnesses.

3. Acquired Hypogonadism:

   • Develops later in life due to factors such as aging, chronic illnesses (e.g., liver disease, kidney disease), or use of certain medications that affect hormone levels.

4. Hypergonadotropic and Hypogonadotropic Hypogonadism:

   • Hypergonadotropic: High levels of gonadotropins (LH and FSH) but low sex steroids (indicative of primary disorder).

   • Hypogonadotropic: Low levels of gonadotropins match low sex steroid levels (indicative of secondary disorder).

Causes of Abnormal Uterine Bleeding (AUB), formerly known as Dysfunctional Uterine Bleeding (DUB):

1. Hormonal Imbalance: Fluctuations in estrogen and progesterone levels can lead to irregular shedding of the endometrium.

   • Common in adolescents and perimenopausal women.

2. Uterine Conditions:

   • Fibroids: Noncancerous growths in the uterus that can cause heavy bleeding.

   • Polyps: Benign growths on the uterine lining.

   • Endometriosis: Tissue similar to the lining of the uterus grows outside the uterus, causing bleeding.

   • Adenomyosis: Endometrial tissue embeds within the uterine muscle, leading to heavy menstrual bleeding.

3. Coagulation Disorders: Conditions that affect blood clotting can lead to excessive bleeding.

   • Examples include von Willebrand disease and platelet function disorders.

4. Medications: Certain medications, such as anticoagulants and hormonal therapies, can lead to abnormal bleeding.

5. Infections: Pelvic inflammatory disease (PID) and other infections can cause irregular bleeding.

6. Pregnancy-related Issues: Miscarriage or ectopic pregnancy can present with abnormal bleeding.

7. Cancer: Endometrial cancer and other reproductive system cancers can lead to abnormal uterine bleeding.

Treatment for Anovulatory Abnormal Uterine Bleeding (AUB):

1. Hormonal Therapy:

   • Combined Oral Contraceptives (COCs): Regulate menstrual cycles and reduce bleeding.

   • Progestin Therapy: Used to induce shedding of the endometrial lining; can be administered as oral pills, injections, or implants.

2. Non-Hormonal Treatment:

   • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Help reduce menstrual bleeding and alleviate pain.

   • Tranexamic Acid: An antifibrinolytic medication that can reduce heavy menstrual bleeding.

3. Lifestyle Modifications:

   • Address underlying issues such as obesity, stress, and excessive exercise.

   • Nutrition and exercise may help in regulating hormonal levels.

4. Surgical Options (if conservative treatments are ineffective):

   • D&C (Dilation and Curettage): Surgical procedure to remove the uterine lining.

   • Endometrial Ablation: Destroys the lining of the uterus to reduce or eliminate bleeding.

   • Hysterectomy: A last resort, removes the uterus if other treatments fail or in cases of severe bleeding or cancer.

Plan of Care for Abnormal Uterine Bleeding (AUB):

1. Laboratory Tests:

   • Hormone level tests (e.g., LH, FSH, estradiol, testosterone) to evaluate for hormonal imbalances.

   • Thyroid function tests (TSH, T4) to rule out thyroid disorders.

   • Coagulation studies to assess for blood clotting disorders.

   • Pregnancy test to rule out pregnancy-related issues.

2. Medications:

   • Hormonal Treatments:

     • Combined Oral Contraceptives (COCs): Regulate menstrual cycles and reduce bleeding.

     • Progestin Therapy: Administered to induce shedding of the endometrial lining.

   • Non-Hormonal Medications:

     • NSAIDs (e.g., ibuprofen): Help reduce both menstrual bleeding and pain.

     • Tranexamic Acid: Reduces heavy menstrual bleeding by preventing clot breakdown.

Mild, Moderate, and Severe Abnormal Uterine Bleeding (AUB):

• Mild AUB:

  • Light flow with regular cycles.

  • Bleeding may last fewer than 7 days.

  • Minimal impact on daily activities and quality of life.

• Moderate AUB:

  • Moderate flow; may require changing sanitary products every 3-4 hours.

  • Potentially prolonged bleeding (>7 days).

  • May cause some impact on daily activities, but stable hemodynamics.

• Severe AUB:

  • Heavy flow requiring frequent changes (every 1-2 hours).

  • Associated with symptoms like dizziness, fatigue, or pallor due to significant blood loss.

  • May result in unstable hemodynamics or need for urgent medical intervention.

Determining Patient Stability and Treatment Planning:

1. Assess Vital Signs: Check heart rate, blood pressure, and respiratory rate.

   • Tachycardia or hypotension suggests instability.

2. Evaluate Hemoglobin/Hematocrit Levels: Determine the degree of anemia.

3. Clinical Assessment: Consider symptoms such as fatigue, dizziness, and level of consciousness.

4. Treatment Plan Based on Stability:

   • Mild: Observation, lifestyle modifications, and possibly NSAIDs.

   • Moderate: Hormonal treatment (e.g., COCs, progestins) and monitoring.

   • Severe: Immediate intervention may be needed, including fluid resuscitation, medications, or surgical options (e.g., D&C or hysterectomy) as appropriate.

Characteristics of Bleeding:

1. Regularity:

   • Irregular: bleeding that does not follow a predictable pattern.

   • Regular: bleeding that occurs in a consistent, predictable manner.

   • Absent: no bleeding episodes.

2. Frequency:

   • Frequent: episodes of bleeding occurring often.

   • Normal: bleeding occurring as expected within regular intervals.

   • Infrequent: bleeding occurring rarely or at extended intervals.

3. Duration:

   • Prolonged: bleeding lasting longer than typical.

   • Normal: bleeding duration within the expected range.

   • Shortened: bleeding occurring for a shorter period than normal.

4. Volume:

   • Heavy: excessive blood loss during episodes.

   • Normal: blood loss within expected limits.

   • Light: minimal blood loss during episodes.